ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 73 filers reported holding ANTHERA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $1,361,000 | -34.4% | 3,197,712 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $2,076,000 | -79.4% | 3,197,712 | 0.0% | 0.00% | -80.0% |
| Q3 2016 | $10,073,000 | +1.9% | 3,197,712 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $9,881,000 | -14.6% | 3,197,712 | 0.0% | 0.01% | -16.7% |
| Q1 2016 | $11,576,000 | -8.2% | 3,197,712 | +17.6% | 0.01% | 0.0% |
| Q4 2015 | $12,612,000 | -18.9% | 2,718,012 | +6.4% | 0.01% | -25.0% |
| Q3 2015 | $15,557,000 | -21.8% | 2,554,512 | +10.7% | 0.01% | -11.1% |
| Q2 2015 | $19,891,000 | +92.8% | 2,307,512 | 0.0% | 0.01% | +80.0% |
| Q1 2015 | $10,315,000 | +380.9% | 2,307,512 | +69.9% | 0.01% | +400.0% |
| Q4 2014 | $2,145,000 | +15.9% | 1,357,812 | +40.9% | 0.00% | 0.0% |
| Q3 2014 | $1,851,000 | -43.4% | 963,912 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $3,268,000 | +20.3% | 963,912 | +18.9% | 0.00% | 0.0% |
| Q1 2014 | $2,716,000 | +9.1% | 810,812 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $2,489,000 | -11.0% | 810,812 | +16.5% | 0.00% | 0.0% |
| Q3 2013 | $2,797,000 | – | 695,712 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 861,723 | $1,174,000 | 0.98% |
| R&F Capital Advisors LP | 171,205 | $111,000 | 0.04% |
| Rhenman & Partners Asset Management AB | 200,000 | $130,000 | 0.02% |
| Rock Springs Capital Management LP | 380,000 | $247,000 | 0.02% |
| WHITE PINE CAPITAL LLC | 35,000 | $23,000 | 0.01% |
| BVF INC/IL | 62,292 | $40,000 | 0.01% |
| Virtu KCG Holdings LLC | 271,239 | $176,000 | 0.00% |
| TURNER INVESTMENTS LLC | 15,000 | $10,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 11,736 | $8,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 36,413 | $24,000 | 0.00% |